Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells

被引：0
|
作者：
Johnson, N. [1 ,2 ]
Bentley, J. [1 ]
Wang, L-Z [1 ]
Newell, D. R. [1 ]
Robson, C. N. [1 ]
Shapiro, G. I. [2 ]
Curtin, N. J. [1 ]
机构：
[1] Newcastle Univ, Northern Inst Canc Res, Paul OGorman Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, England
[2] Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA
来源：
BRITISH JOURNAL OF CANCER | 2024年
关键词：
D O I：
10.1038/s41416-024-02813-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：955 / 955
页数：1
相关论文
共 50 条
  • [31] Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2
    Danilov, Alexey V.
    Hu, Shanhu
    Orr, Bernardo
    Godek, Kristina
    Mustachio, Lisa Maria
    Sekula, David
    Liu, Xi
    Kawakami, Masanori
    Johnson, Faye M.
    Compton, Duane A.
    Freemantle, Sarah J.
    Dmitrovsky, Ethan
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (11) : 2758 - 2766
  • [32] Cyclin-dependent kinase 2 to 1 specific activity ratio predicts response to epirubicin and paclitaxel in human breast cancer
    Kim, S. J.
    Myoshi, Y.
    Taguchi, T.
    Tamaki, Y.
    Noguchi, S.
    Tsukamoto, F.
    Akazawa, K.
    Nakayama, S.
    Matsushima, T.
    Torikoshi, Y.
    Ishihara, H.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S90 - S90
  • [33] Pre-clinical evaluation of novel anti-angiogenic agents as breast cancer therapeutics
    McGarrigle, S. A.
    Murphy, A.
    Kennedy, B. N.
    Reynolds, A.
    O'Sullivan, J. N.
    Kennedy, M. J.
    Connolly, E. M.
    CANCER RESEARCH, 2013, 73
  • [34] Pre-Clinical Evaluation of Novel Anti-Angiogenic Agents as Breast Cancer Therapeutics
    McGarrigle, S.
    Murphy, A.
    Kennedy, B.
    Reynolds, A.
    O'Sullivan, J.
    Kennedy, M. J.
    Connolly, E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 : S332 - S332
  • [35] Association of cyclin-dependent kinase inhibitor 2A/B with increased risk of developing breast cancer
    Seifi, Sima
    Pouya, Farzaneh
    Rahmani, Mahsa
    Mehramiz, Mehrane
    Rastgar-Moghadam, Azam
    Gharib, Masoumeh
    Rahmani, Farzad
    Shahidsales, Soodabeh
    Hassanian, Seyed Mahdi
    Khazaei, Majid
    Dadjoo, Parisa
    Parvin, Seyede Sara
    Yazdinezhad, Yeganeh
    Parizadeh, Seyed Mohammad Reza
    Ferns, Gordon A.
    Fathi, Mehdi
    Avan, Amir
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (06) : 5141 - 5145
  • [36] Time to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor Use
    Endo, Yuka
    Yoshimura, Akiyo
    Sawaki, Masataka
    Hattori, Masaya
    Kotani, Haruru
    Kataoka, Ayumi
    Horisawa, Nanae
    Ozaki, Yuri
    Nozawa, Kazuki
    Takatsuka, Daiki
    Isogai, Ayaka
    Iwata, Hiroji
    JOURNAL OF BREAST CANCER, 2022, 25 (04) : 296 - 306
  • [37] Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition
    Au-Yeung, George
    Lang, Franziska
    Azar, Walid J.
    Mitchell, Chris
    Jarman, Kate E.
    Lackovic, Kurt
    Aziz, Diar
    Cullinane, Carleen
    Pearson, Richard B.
    Mileshkin, Linda
    Rischin, Danny
    Karst, Alison M.
    Drapkin, Ronny
    Etemadmoghadam, Dariush
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2017, 23 (07) : 1862 - 1874
  • [38] Anti-estrogen-resistant breast cancer cells are sensitive to cisplatin plus TRAIL treatment
    Yin, Shuping
    Rishi, Arun K.
    Reddy, Kaladhar B.
    ONCOLOGY REPORTS, 2015, 33 (03) : 1475 - 1480
  • [39] Paullones, a series of cyclin-dependent kinase inhibitors: Synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity
    Schultz, C
    Link, A
    Leost, M
    Zaharevitz, DW
    Gussio, R
    Sausville, EA
    Meijer, L
    Kunick, C
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (15) : 2909 - 2919
  • [40] Unliganded estrogen receptor α inhibits breast cancer cell growth through interaction with a cyclin-dependent kinase inhibitor (p21WAF1)
    Maynadier, Marie
    Ramirez, Jean-Marie
    Cathiard, Ame-Marie
    Platet, Nadine
    Gras, Delphine
    Gleizes, Michel
    Sheikh, M. Saeed
    Nirde, Philippe
    Garcia, Marcel
    FASEB JOURNAL, 2008, 22 (03): : 671 - 681
12345